Found: 19
Select item for more details and to access through your institution.
Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established Disease.
- Published in:
- Frontiers in Physiology, 2020, v. 11, p. 1, doi. 10.3389/fphys.2020.00184
- By:
- Publication type:
- Article
Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 8174, doi. 10.3390/ijms24098174
- By:
- Publication type:
- Article
Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD).
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 6, p. 769, doi. 10.3390/metabo13060769
- By:
- Publication type:
- Article
Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.
- Published in:
- Nucleic Acids Research, 2016, v. 44, n. 22, p. 10929, doi. 10.1093/nar/gkw703
- By:
- Publication type:
- Article
Clonal Characterization of Rat Muscle Satellite Cells: Proliferation, Metabolism and Differentiation Define an Intrinsic Heterogeneity.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008523
- By:
- Publication type:
- Article
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 16105, doi. 10.1038/ncomms16105
- By:
- Publication type:
- Article
Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model.
- Published in:
- Human Molecular Genetics, 2021, v. 30, n. 15, p. 1398, doi. 10.1093/hmg/ddab136
- By:
- Publication type:
- Article
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 19, p. 3301, doi. 10.1093/hmg/ddz167
- By:
- Publication type:
- Article
Functional muscle recovery following dystrophin and myostatin exon splice modulation in aged mdx mice.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 18, p. 3091, doi. 10.1093/hmg/ddz125
- By:
- Publication type:
- Article
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 10, p. 1694, doi. 10.1093/hmg/ddz007
- By:
- Publication type:
- Article
Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 2, p. 345, doi. 10.1038/mt.2010.261
- By:
- Publication type:
- Article
Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa guanidine Morpholino Oligomer Treatment.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 159, doi. 10.1038/mt.2010.212
- By:
- Publication type:
- Article
Expression of the Pro-Fibrotic Marker Periostin in a Mouse Model of Duchenne Muscular Dystrophy.
- Published in:
- Biomedicines, 2024, v. 12, n. 1, p. 216, doi. 10.3390/biomedicines12010216
- By:
- Publication type:
- Article
An Induced Pluripotent Stem Cell-Derived Human Blood–Brain Barrier (BBB) Model to Test the Crossing by Adeno-Associated Virus (AAV) Vectors and Antisense Oligonucleotides.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2700, doi. 10.3390/biomedicines11102700
- By:
- Publication type:
- Article
Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit DUX4 Expression.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071623
- By:
- Publication type:
- Article
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2020, v. 11, n. 3, p. 768, doi. 10.1002/jcsm.12542
- By:
- Publication type:
- Article
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2019, v. 10, n. 5, p. 1016, doi. 10.1002/jcsm.12438
- By:
- Publication type:
- Article
Targeted Antisense Oligonucleotide-Mediated Skipping of Murine Postn Exon 17 Partially Addresses Fibrosis in D2. mdx Mice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6113, doi. 10.3390/ijms25116113
- By:
- Publication type:
- Article
Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2024, v. 15, n. 5, p. 1976, doi. 10.1002/jcsm.13546
- By:
- Publication type:
- Article